Open the map

ResMedRMD

Medtech & devices · NYSE · USA

$226.73
Up 0.3% todayClose

Down 6.2% this year but +13.2% since June 26, ahead of the life science sector at +10.7%. ResMed supplies 1 mapped company.

Market cap
$31.5B
This year
−6.2%
1 year
−20.2%
P/E
20.7
P/S
5.6
P/B
4.8

Price vs the life science sector

since Jun 26RMDLife science sector, equal weight
ResMed (RMD) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. RMD: +13.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8RMD +13.2%Sector +10.7% ResMed (RMD) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. RMD: +13.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8RMD+13.2%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%RMDResMed

Customers 1

Open the full chain →

About ResMed

CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.

Theme exposure

Sleep & respiratorySleep apneaRespiratory equipmentDigital health

Products

  • CPAP devices & masks
  • Sleep & respiratory equipment
  • Digital health software

Competitors

  • Philips
  • Fisher & Paykel Healthcare
  • Compumedics

Risks

  • GLP-1 impact on sleep apnea
  • Competition

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Intuitive SurgicalISRG+0.2%MedtronicMDT+2.6%StrykerSYK+0.6%Boston ScientificBSX+1.1%Becton DickinsonBDX+1.4%Edwards LifesciencesEW−1.8%GE HealthCareGEHC−0.7%Zimmer BiometZBH+0.4%

Compare RMD

Side by side with the largest companies in the same segment.

RMD vs ISRGRMD vs MDTRMD vs SYKRMD vs BSXRMD vs BDXRMD vs EW

See where ResMed sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →